The evolving concept of Treatment-Resistant Schizophrenia

被引:1
|
作者
Quintero, Javier [1 ]
Barbudo del Cura, Eduardo
Lopez-Ibor, Maria I. [2 ]
Lopez-Ibor, Juan J. [2 ]
机构
[1] Univ Complutense, Fac Med, Dept Psychiat & Med Psychol, Hosp Univ Infanta Leonor,Psychiat Serv, Madrid 28031, Spain
[2] Univ Complutense, Fac Med,Hosp Clin San Carlos IdISSC,Ctr Invest Bi, Dept Psychiat & Med Psychol,Inst Invest Sanitaria, Hosp Clin San Carlos,Inst Psiquiatria & Salud Men, Madrid 28031, Spain
来源
ACTAS ESPANOLAS DE PSIQUIATRIA | 2011年 / 39卷 / 04期
关键词
Schizophrenia; Resistant schizophrenia; Psychosis; Chronic schizophrenia; Treatment resistant schizophrenia; Antipsychotics; Comorbidity; ANTIPSYCHOTIC MEDICATION ADHERENCE; AGGRESSIVE-BEHAVIOR; 1ST-EPISODE SCHIZOPHRENIA; AUGMENTATION STRATEGIES; PSYCHOSOCIAL TREATMENT; TREATMENT RESPONSE; DRUG-INTERACTIONS; RISK-FACTORS; CLOZAPINE; DISORDER;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Schizophrenia is a chronic disease of body and mind that affects 1% of the population. The existence of the person with schizophrenia should be understood, at least, from two perspectives: one considering the integration of the individual into the social community, another understanding that there is a patient with a medical problem treatable with medications and psychotherapies. There is a large group of patients with 'treatment-resistant schizophrenia," that is, cases in which a minimum degree of remission with conventional treatments is not obtained. These cases have pointed to the fact that even today we still lack an integrative treatment model obtained through the assembling of specific interventions with verifiable effectiveness. The concept of treatment-resistant schizophrenia should have evolved in accordance with the advancing of the currently available knowledge and therapeutic resources. Why hasn't this happened? This article reviews the history of the concept of "resistance" to account for such failure and proposes a methodological approach to overcome this stagnation.
引用
收藏
页码:236 / 250
页数:15
相关论文
共 50 条
  • [41] Management of treatment-resistant schizophrenia with olanzapine
    Thomas, SG
    Labbate, LA
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1998, 43 (02): : 195 - 196
  • [42] The Role of Clozapine in Treatment-Resistant Schizophrenia
    Kane, John M.
    Correll, Christoph U.
    JAMA PSYCHIATRY, 2016, 73 (03) : 187 - 188
  • [43] Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
    Tseng, Ping-Tao
    Chen, Mu-Hong
    Liang, Chih-Sung
    WORLD JOURNAL OF PSYCHIATRY, 2022, 12 (08): : 1102 - 1104
  • [44] Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia
    Wimberley, Theresa
    Gasse, Christiane
    Meier, Sandra Melanie
    Agerbo, Esben
    MacCabe, James H.
    Horsdal, Henriette Thisted
    SCHIZOPHRENIA BULLETIN, 2017, 43 (05) : 1064 - 1069
  • [45] Is treatment-resistant depression a useful concept?
    Malhi, Gin S.
    Byrow, Yulisha
    EVIDENCE-BASED MENTAL HEALTH, 2016, 19 (01) : 1 - 3
  • [47] THE COMBINATION OF AMISULPIRIDE AND CLOZAPINE FOR THE TREATMENT OF TREATMENT-RESISTANT SCHIZOPHRENIA
    Istikoglou, C.
    Foutsitzis, D.
    Papouli, F.
    Polonifis, N.
    Kanellos, P.
    Theodorakopoulos, G.
    Kogeorgos, J.
    Vlissides, D.
    Michelidakis, K.
    Salla, T.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [48] A REVIEW OF CLOZAPINE - AN ANTIPSYCHOTIC FOR TREATMENT-RESISTANT SCHIZOPHRENIA
    STEPHENS, P
    COMPREHENSIVE PSYCHIATRY, 1990, 31 (04) : 315 - 326
  • [49] Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective
    Dold, Markus
    Leucht, Stefan
    EVIDENCE-BASED MENTAL HEALTH, 2014, 17 (02) : 33 - 37
  • [50] Accessing Gene Expression in Treatment-Resistant Schizophrenia
    Patricia N. Moretti
    Vanessa K. Ota
    Eduardo S. Gouvea
    Mariana Pedrini
    Marcos L. Santoro
    Fernanda Talarico
    Leticia M. Spindola
    Carolina Muniz Carvalho
    Cristiano Noto
    Gabriela Xavier
    Elisa Brietzke
    Ary Gadelha
    Rodrigo Bressan
    Jair Mari
    Sintia Belangero
    Molecular Neurobiology, 2018, 55 : 7000 - 7008